Dominari Holdings Inc. (DOMH)
Largest Insider Buys in Sector
DOMH Stock Price History Chart
DOMH Stock Performance
About Dominari Holdings Inc.
Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, …
Insider Activity of Dominari Holdings Inc.
Over the last 12 months, insiders at Dominari Holdings Inc. have bought $181,885 and sold $0 worth of Dominari Holdings Inc. stock.
On average, over the past 5 years, insiders at Dominari Holdings Inc. have bought $231,109 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Hayes Anthony (CEO) — $120,250. Wool Kyle Michael (President) — $103,897. Devall Christopher Franklin (COO) — $17,863.
The last purchase of 3,482 shares for transaction amount of $8,357 was made by Hayes Anthony (CEO) on 2024‑05‑30.
List of Insider Buy and Sell Transactions, Dominari Holdings Inc.
| 2024-05-30 | CEO | 3,482 0.0788% | $2.40 | $8,357 | -15.42% | |||
| 2024-05-29 | CEO | 1,158 0.0246% | $2.25 | $2,606 | -20.26% | |||
| 2024-05-29 | President | 5,000 0.1037% | $2.20 | $11,000 | -20.26% | |||
| 2024-04-08 | President | 8,500 0.2394% | $2.99 | $25,390 | -34.45% | |||
| 2024-04-05 | CEO | 13,500 0.366% | $2.88 | $38,823 | -40.76% | |||
| 2024-04-04 | CEO | 3,944 0.0975% | $2.62 | $10,339 | -33.81% | |||
| 2024-04-04 | President | 19,000 0.5139% | $2.87 | $54,511 | -33.81% | |||
| 2023-12-26 | COO | 7,000 0.1684% | $2.55 | $17,863 | -25.38% | |||
| 2023-12-26 | President | 5,000 0.1225% | $2.60 | $12,997 | -25.38% | |||
| 2023-12-20 | CEO | 70,000 1.3215% | $2.00 | $140,168 | -4.39% | |||
| 2023-12-12 | CEO | 4,000 0.0755% | $2.00 | $8,012 | +3.06% | |||
| 2023-12-12 | 4,000 0.0766% | $2.03 | $8,122 | +3.06% | ||||
| 2023-11-30 | COO | 1,000 0.0215% | $2.28 | $2,278 | -9.69% | |||
| 2023-11-28 | COO | 1,000 0.0213% | $2.26 | $2,259 | -9.29% | |||
| 2023-11-27 | 1,000 0.0207% | $2.20 | $2,200 | -5.96% | ||||
| 2023-11-24 | CEO | 1,481 0.0302% | $2.16 | $3,200 | -7.62% | |||
| 2023-11-22 | CEO | 1,323 0.0261% | $2.09 | $2,765 | 0.00% | |||
| 2023-11-20 | director | 2,000 0.0387% | $2.05 | $4,103 | +3.00% | |||
| 2023-11-16 | CEO | 2,500 0.0463% | $1.97 | $4,916 | +4.04% | |||
| 2023-11-14 | CEO | 2,500 0.0455% | $1.93 | $4,825 | +6.74% |
Insider Historical Profitability
| Hayes Anthony | CEO | 223146 3.5217% | $1.27 | 20 | 0 | <0.0001% |
| Devall Christopher Franklin | COO | 30033 0.474% | $1.27 | 5 | 0 | <0.0001% |
| Wool Kyle Michael | President | 27750 0.438% | $1.27 | 22 | 0 | <0.0001% |